Literature DB >> 29404120

New-Onset Sarcoidosis After Remission of Cushing's Syndrome.

Alev Selek1, Serap Barış2, Berrin Çetinaslan1, Zeynep Cantürk1, İlhan Tarkun1, Zeynep Akyay1.   

Abstract

Exposure to high levels of endogenous or exogenous glucocorticoids suppresses the inflammatory response genes. Excessive endogenous hypercortisolism may mask the active inflammatory diseases. Rebound immune modulation may occur after Cushing's syndrome (CS) remission, leading to the new onset of autoimmune diseases. Here, we report a 27-year-old female patient who was recently diagnosed with sarcoidosis after remission of CS. Normal thorax imaging showed that the patient was free of disease during the course of CS and without any symptoms of sarcoidosis. After complete remission of CS, she was diagnosed with sarcoidosis based on clinical and radiological evidence. Excessive hypercortisolism may suppress the active inflammatory stage of sarcoidosis. However, the disease became apparent after the reduction of cortisol levels following the treatment of CS.

Entities:  

Keywords:  Cushing’s syndrome; Sarcoidosis; hypercortisolism

Year:  2015        PMID: 29404120      PMCID: PMC5792112          DOI: 10.5578/ttj.17.1.007

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  10 in total

1.  Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up.

Authors:  G Ntali; A Asimakopoulou; T Siamatras; J Komninos; D Vassiliadi; M Tzanela; S Tsagarakis; A B Grossman; J A H Wass; N Karavitaki
Journal:  Eur J Endocrinol       Date:  2013-10-08       Impact factor: 6.664

2.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

3.  Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature.

Authors:  Filipe da Mota; Cathy Murray; Shereen Ezzat
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

4.  Immunoendocrine interactions and autoimmunity.

Authors:  A M McGregor
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

5.  Long-term mortality after transsphenoidal surgery for Cushing disease.

Authors:  B Swearingen; B M Biller; F G Barker; L Katznelson; S Grinspoon; A Klibanski; N T Zervas
Journal:  Ann Intern Med       Date:  1999-05-18       Impact factor: 25.391

Review 6.  Regulatory T cells, inflammation and the allergic response-The role of glucocorticoids and Vitamin D.

Authors:  Sarah Dimeloe; Alexandra Nanzer; Kimuli Ryanna; Catherine Hawrylowicz
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-19       Impact factor: 4.292

Review 7.  Imaging in sarcoidosis.

Authors:  Hilario Nunes; Pierre-Yves Brillet; Dominique Valeyre; Michel W Brauner; Athol U Wells
Journal:  Semin Respir Crit Care Med       Date:  2007-02       Impact factor: 3.119

Review 8.  Sarcoidosis following Cushing's syndrome: A report of two cases and review of the literature.

Authors:  S Schaefer; S Meyer; C C Brueck; M Weber; D Luedecke; H J Wagner; P H Kann
Journal:  Exp Clin Endocrinol Diabetes       Date:  2010-02-16       Impact factor: 2.949

9.  Current best practice in the management of pulmonary and systemic sarcoidosis.

Authors:  Emily N Amin; Douglas R Closser; Elliott D Crouser
Journal:  Ther Adv Respir Dis       Date:  2014-07-17       Impact factor: 4.031

10.  Rebound thymic hyperplasia after treatment of Cushing's syndrome.

Authors:  J L Doppman; E H Oldfield; G P Chrousos; L Nieman; R Udelsman; G B Cutler; D L Loriaux
Journal:  AJR Am J Roentgenol       Date:  1986-12       Impact factor: 3.959

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.